Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. [electronic resource]
- The British journal of dermatology Apr 2013
- 825-36 p. digital